Clinical Trials Logo

Clinical Trial Summary

Recurrent pregnancy loss (RPL) is a multifactorial disorder defined by the American Society for Reproductive Medicine (ASRM) as two or more clinical miscarriages (CMs). However, US guidelines differ with European guidelines which defined recurrent miscarriage as three consecutive prior pregnancy losses (The Royal College of Obstetricians and Gynaecologists Green-Top Guideline, 2011). Thus, there is currently no uniformly agreed upon definition of RPL, the ASRM recommends that a clinical evaluation for RPL commence following two early pregnancy losses, and that a threshold of three prior pregnancy losses be utilized for epidemiologic studies (The Practice Committee of the American Society for Reproductive Medicine, 2012). Although the overall incidence of RPL is low and estimated at 5% of women (The Practice Committee of the American Society for Reproductive Medicine, 2012), it presents a significant diagnostic and treatment challenge for both patients and clinicians. Guidelines for the evaluation of patients with RPL include evaluation of the uterine cavity and blood work to determine parental karyotypes and the presence of anti-phospholipid antibodies (APLA). In at least 50% of patients, however, an etiology for RPL is not identified (Stirrat, 1990; Stephenson, 1996; Stephenson and Kutteh, 2007; The Practice Committee of the American Society for Reproductive Medicine, 2012). The ASRM recommends expectant management as the current standard of care for patients with unexplained RPL (The Practice Committee of the American Society for Reproductive Medicine, 2012). Counseling patients with unexplained RPL to pursue expectant management presents several challenges. Patients often feel an urgency to conceive and expectant management can feel like a passive and time-consuming approach to conception. In addition, patients often carry a significant amount of guilt and grief in association with miscarriage. Attempting spontaneous conception can feel emotionally vulnerable; Despite reassurance of good prognosis, patients doubt that a subsequent pregnancy will be successful (Lachmi-Epstein et al., 2012). For all of these reasons, IVF and preimplantation genetic testing (PGT) have been investigated as a treatment strategy in RPL patients with the goals of shortening time to pregnancy, decreasing CM rates and increasing live birth (LB) rates.


Clinical Trial Description

The role of aneuploidy in CM is well known, with over 50% of pregnancy losses attributed to fetal chromosomal abnormalities (Viaggi et al., 2013). Furthermore, for patients greater than 35 years of age with RPL, fetal aneuploidy is responsible for up to 80% of first trimester losses (Marquard et al., 2010). Due to the prevalence of aneuploidy in first trimester losses and in the RPL population, PGT has been proposed as a method for reducing miscarriage by selecting only euploid embryos for transfer (Shahine and Lathi, 2014). The ultimate effect of PGT on increasing LB rates in the RPL population and the time interval to conception are areas of investigation. Current studies are largely retrospective in design with several limitations. For example: Inconsistent definitions of CM and RPL are employed. In addition, the treatment group (IVF and PGT) has been compared with a variety of control groups including IVF without PGT, a control infertile population, or to predicted LB and CM rates based on age and clinical history, but has not been compared with expectant management (Shahine and Lathi, 2014). Finally, the majority of studies report clinical outcomes only of patients who reach PGT biopsy and/or embryo transfer, so all possible cycle outcomes are not captured (Hodes-Wertz et al., 2012). For the absence of well-designed prospective studies with high level of evidence comparing IVF and PGT to the current standard of care, expectant management, have been performed to date for the treatment of RPL patients. The objective of this study is to perform an intent to treat analysis comparing live birth rate of IVF and PGT to expectant management in fertile RPL patients in one year followed- up period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05457335
Study type Observational [Patient Registry]
Source Shanghai First Maternity and Infant Hospital
Contact Zhi Qin Chen, MD
Phone 86-21-540355206
Email ptchen1@hotmail.com
Status Not yet recruiting
Phase
Start date July 15, 2022
Completion date July 15, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06313112 - Impact of Food Insecurity on Utilization of Maternal Healthcare Services and Birth Outcomes in Slums in Pune, India
Recruiting NCT03242746 - Cervical Morphological Changes on Pregnancy Outcome
Recruiting NCT04515134 - Assessment of Follicular Fluid Level of Coenzyme Q10 in Women Undergoing ICSI
Completed NCT03740568 - Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes. N/A
Completed NCT05355038 - Effect of Lifestyle Modification on Pregnancy Outcome for GDM N/A
Recruiting NCT05506631 - Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening N/A
Terminated NCT03489174 - Routine Pregnancy Screening for Women on Opioid Substitution Therapy N/A
Completed NCT03748576 - A Prospective Randomized Controlled Trial of Mobile Medical Used for Management of Pregnant Women N/A
Active, not recruiting NCT03113331 - The 3D Cohort Study (Design, Develop, Discover)
Active, not recruiting NCT03215368 - The Ma'Anshan Birth Cohort (MABC)
Recruiting NCT04930276 - Diet-glucose-gut Microbiome Net in Women With GDM N/A
Enrolling by invitation NCT04977466 - NIH Intramural Research Program s Pregnancy Registry Protocol for Subjects and Their Partners
Withdrawn NCT05847140 - A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy
Active, not recruiting NCT02271490 - Acrosome Reaction Induction Prior to ICSI N/A
Not yet recruiting NCT04434495 - Outcome of Platelet Rich Plasma in ICSI Patients, a Randomized Controlled Trial Phase 2
Not yet recruiting NCT04434547 - A RCT on the Effect of Platelets Rich Plasma in ICSI Patients With Recurrent Implantation Failure Phase 2
Completed NCT05647538 - Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Outcome
Completed NCT00878098 - Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
Completed NCT01653392 - BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Recruiting NCT05733377 - Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome